Category: Pharmaceutical

Categories
Pharmaceutical

Targeted Therapy Drugs Expand the Bandwidth of Injectable Oncology Small Molecule Drugs Industry Finds Fact.MR

According to a recent study by Fact.MR, sales of oncology small molecule drugs are envisaged to surpass US$ ~66 Bn in 2019, up from revenues worth US$~63 Bn attained in 2018.

Gains are prominently underpinned by spectacular rise in cancer prevalence, rapid proliferation of oncology centers, and improving availability of oral small molecule drugs for cancer treatment.  The report suggests that a number of oncology small molecule drugs are getting approvals, which are potentially effective in treating unresectable cancers, which clearly points to a positive growth outlook for the oncology small molecule drugs market.

The oncology small molecule drugs market is growing in parallel with the increasing collaborative efforts and initiatives of biopharma companies, investing in early cancer diagnosis and therapeutics. Increasing number of pipeline studies and rising R&D funding for healthcare industry will continue to create fresh growth avenues in the form of NPDs, thereby driving the growth of oncology small molecule drugs market.

Click Here To get a Sample Report (Including Full TOC, Table & Figures) https://www.factmr.com/connectus/sample?flag=S&rep_id=3747

50% of Sales Remain Concentrated in North America

According to the Fact.MR study, sales of oncology small molecule drugs will remain concentrated in North America, primarily driven by the high prevalence of cancers and advanced treatment infrastructure in the region. Increasing funds from governments as well as private organizations for the development of advanced and improved cancer treatments, will remain the key growth influencers associated with the growth of oncology small molecule drugs market in North America.

In 2018, North America accounted for half the sales of oncology small molecule drugs, and will continue to remain the most lucrative market for stakeholders. Stringent approval regulations, especially in developing countries, such as Japan, will continue to limit the penetration of oncology small molecule drugs in these regions to an extent. Furthermore, Japan, peculiarly having one of the most difficult approval processes for new drug molecules, holds an impressive opportunistic potential for market leaders that are striving for quicker drug approvals by improving R&D processes and expansion strategies, targeting developing countries.

The study opines that advanced and orally viable cancer drugs are adding value to the attractive market potential of oncology small molecule drugs, among an ever-growing pool of patients. Broader factors concerning cancer treatment, especially the unavailability of proper drugs in several regions and laser-sharp focus on increasing drug absorption in cells by leveraging small molecule drugs, are likely to shape revenue generation in the oncology small molecule drugs market.

Connect To an Expert https://www.factmr.com/connectus/sample?flag=AE&rep_id=3747

oncology small molecule drugs market taxonomy

Key Prominent Players

  • Novartis AG
  • Sanofi S.A.
  • AbbVie Inc.
  • AstraZeneca plc
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • AstraZeneca plc.

The research report published by Fact.MR on the Oncology Small Molecule Drugs Market provides a detailed overview of the demands and consumptions of various products/services associated with the growth dynamics of the market during the forecast period. The in-depth market estimation of various opportunities in the segments is expressed in volumes and revenues. The insights and analytics on the Oncology Small Molecule Drugs Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

 

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa, Rest of MEA)

Read More Trending Reports of Fact.MR: – https://www.prnewswire.com/news-releases/home-diagnostics-market-witnessing-heightened-start-up-investments-offering-specialized-solutions-factmr-301212625.html

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Oncology Small Molecule Drugs Market report offers detailed assessments and quantitative evaluations that shed light on numerous key aspects that have shaped its evolution over the historical period. In coming years, some of the key aspects that will shape the growth prospects during the forecast period are objectively covered in the study.

To Get All-In Insights On the Regional Landscape of The Report Market, Buy Now

https://www.factmr.com/checkout/3747

The research attempts to answer many queries such as:

  1. What needs are the leading manufacturers trying to meet by the forecast period 2025?
  2. What challenges will vendors running the Oncology Small Molecule Drugs Market go through?
  3. What aspects do the consumers look up while buying Oncology Small Molecule Drugs?
  4. How will the competitive framework look like between the foreseeable period 2018 to 2025?
  5. At present, who is buying your product or service globally?
  6. Who are your primary contenders?
  7. What will be the cost of the products and facilities across various regions?
  8. What are the trends affecting the performance of the Oncology Small Molecule Drugs Market?

Need More Information about Report Methodology? Click here

https://www.factmr.com/connectus/sample?flag=RM&rep_id=3747

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Nano Healthcare Technology Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Medical Suction Devices Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

Medical Grade Silicone Market Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Reach out to us with your goals, and we’ll be an able research partner.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Revenues from PSA Prostate Cancer Diagnostic Tests Is Projected to Register the Highest CAGR in the Market through 2031

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to the latest report by Fact.MR, the global demand for prostate cancer diagnostics is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of revenues, the market is projected to reach US$ 823.5 Mn in 2017; by 2022 this number is projected to surpass US$ 1,000 Mn.

Diagnosis of prostate cancer is becoming a critical undertaking for medical organizations. Newer treatments on prostate cancer are being developed by considering the scope of diagnostic approach. This emergence of diagnosis-associated treatments on prostate cancer is expected to render higher medical efficiency, providing effective outputs at minimal healthcare spending.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=58

Through and through, medical organizations are scanning key criteria associated with diagnosis of prostate cancer, tracking parameters such as age of the patient, ethnicity, family medical history, and diet. Considering the sensitivity of organs in the prostate area, patients are also adopting non-invasive diagnosis tests, which is ultimately impacting the products sold in the global market for prostate cancer diagnostics.

Key players in the global market for prostate cancer diagnostics include

Abbott Laboratories
Biocept, Inc.
AstraZeneca plc.
Cancer Genetics, Inc.
Danaher Corporation
Bayer Aktiengesellschaft
Becton
Dickinson and Company
Agilent Technologies
Foundation Medicine, Inc.
Myriad Genetics Inc.

Global Prostate Cancer Diagnostics Market: Segmentation

For clearer understanding of the Prostate Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Prostate Cancer Diagnostics Market, which is essential to make sound investments.

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Prostate Cancer Diagnostics Market.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=58

5 Estimations from Fact.MR’s Report on the Global Prostate Cancer Diagnostics Market

  1. North America will continue to be the most lucrative region in the global prostate cancer diagnostics market, in terms of revenues. The prostate cancer diagnostics market in North America and Europe are expected to exhibit similar CAGRs through 2022.
  2. The market in Asia-Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022. In contrast, prostate cancer diagnostics market in Middle East & Africa will continue to register a sluggish expansion during the forecast period.
  3. PSA tests will continue to be the largest adopted tests for diagnosis of prostate cancer across the globe. PSA test segment is projected to register the highest CAGR in the market through 2022.
  4. Hospital-associated labs are expected to remain the largest end-users of prostate cancer diagnostics in the global market, however revenues from prostate cancer diagnostics in hospital-associated labs will register the lowest CAGR in the market through 2022.
  5. In terms of revenues, cancer research institutes are expected to register the highest CAGR in the market through 2022. Independent diagnostics labs will remain the second largest end users of the prostate cancer diagnostics during the forecast period.

The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

By Test Type

  • PSA Tests
  • CTC Tests
  • Immunohistochemistry
  • PCA3 test

By End User

  • Hospital Associated Labs
  • Independent Diagnostic Laboratories
  • Cancer Research Institutes

Following Questions Answers Covered in the Report are:

  • How will the global Prostate Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Prostate Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Prostate Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=58

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/06/1996513/0/en/Fact-MR-Projects-Global-Sleep-Mask-Sales-to-Grow-at-4-CAGR-over-2019-2029-Wrap-around-Sleep-Masks-Emerging-Lucrative.html

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Rising Prevalence of Osteoporosis among Women Is Expected to Trigger the Demand for Estrogen Replacement Therapy

The Demand for hormone replacement therapy is foreseen to expand at a significant pace with sales of hormone replacement therapy products crossing US$ 12,000 Mn by 2019 end.

Rising incidences of osteoporosis fractures coupled with growing menopause rates among women have remained instrumental in driving the demand for hormone replacement therapy. Fact.MR envisages that the demand for hormone replacement therapy is projected to expand at a CAGR of 6.0% in terms of value throughout the period of forecast, 2018-2028.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=2224

Disorders associated with hormonal imbalance continue to influence the use of hormone replacement therapy worldwide. Hormone replacement therapy demand is further pushed with macroeconomic aspects such as growing geriatric population and significant increase in healthcare expenditure worldwide. Growing age directly impacts secretion of hormones such as progesterone and estrogen in women, which is expected to trigger the use of estrogen hormone replacement therapy.

Expanding range of menopausal window (45-55 years) coupled with growing number of postmenopausal patients are few of the key factors influencing the growth of the hormone replacement therapy market.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2224

According to the report, the demand for estrogen hormone replacement therapy is expected to grow on the back of growing menopausal rate worldwide. The sales of estrogen hormone replacement therapy are likely to surpass US$ 18,000 Mn by 2028, higher than those of other hormone replacement therapy products including thyroid and growth hormone related hormone replacement therapy products, says the report.

Sales of hormone replacement therapy products through hospital pharmacies and retail pharmacies are likely to be on an upswing with developers of hormone replacement therapy products relying on these channels than online selling. Retail pharmacies are expected to remain an attractive distribution channel for hormone replacement therapy products, with sales accounting for a larger revenue share of the overall hormone replacement therapy market. The sales of hormone replacement therapy through clinics are projected to grow at a steady during the 2018-2028 timeline.

hormone replacement therapy market 0

Full Access of This Report Is Available At
https://www.factmr.com/checkout/2224

The hormone replacement therapy market is expected to remain influenced by increasing government support apropos to women’s health. Governments and non-profit organizations of various countries are spreading awareness regarding hormone replacement therapy along with providing free treatments to lower and middle class people. Regulatory authorities such as FDA are also contributing to the cause of supporting women’s health by launching initiatives such as Take Time To Care (TTTC) programs. This aspect is likely to support the growth of the hormone replacement therapy market in the coming years.

Sales of hormone replacement therapy products are likely to remain concentrated among developed countries of North America and Europe. Tug-of-war between North America and Europe apropos to demand for hormone replacement therapy has been witnessed since the past couple of years, with the latter gaining tempo over the former, says the report.

Stakeholders in the hormone replacement therapy can find attractive opportunities in developed countries in North America, particularly the United States. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause every day, reaching a count of over 2 million annually. This has translated into significant adoption of hormone replacement therapy in the country. The demand for hormone replacement therapy in the US is also accompanied by higher GDP per capita, triggering high healthcare expenditure.

For More Insights
https://www.biospace.com/article/increasing-kidney-disorder-prevalence-coupled-with-unhealthy-lifestyle-habits-are-driving-growth-of-global-bartter-syndrome-treatment-market

The report also foresees that the hormone replacement therapy market in Asia Pacific excluding Japan (APEJ) region is poised to expand at a relatively higher pace as compared to other regions. According to the report, the APEJ hormone replacement therapy market is projected to expand at a stellar pace of 7.2% during the assessment period. This growth can be attributed to increasing population coupled with higher life expectancy in emerging economies such as India and China. Against this backdrop, stakeholders in hormone replacement therapy market can expect optimistic growth in the region in the years to follow, leveraging its lucrativeness from an investment standpoint.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

 

Categories
Pharmaceutical

Demand for Powered ENT Surgical System Devices Is Projected to Grow at 6.4% CAGR through 2028

ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to,

  • Technological advancements enhancing ENT procedure efficiency and outcome
  • Reimbursement policies in favor of ENT surgeries
  • Product developments accommodating demand trend such as minimal invasion

The medical technology industry has shifted from a traditional marketing model to a care delivery model. Following the new business approach, Tier 1 and Tier 2 players portray hegemony in the market and continue to introduce disruptive technology innovations in ENT surgical devices.

Click Here To get a Sample Report (Including Full TOC, Table & Figures):-
https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

The study analyzes crucial trends that are currently determining market growth. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders and emerging players associated with Dual Interface ENT Surgical Devices Market. The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period.

Key Segments Covered

  • Product Type
    • ENT Surgical Laser Devices
    • ENT Surgical Hand Instruments
    • Powered ENT Surgical System Devices
    • Radiofrequency ENT Electrosurgical Devices
    • ENT Surgery Workstations
    • ENT Surgical Navigation Systems
    • ENT Visualization Systems
    • ENT Surgical Microscopes
  • End User
    • ENT Surgical Devices for Hospitals
    • ENT Surgical Devices for Ambulatory Surgical Centers
    • ENT Surgical Devices for ENT Clinics
  • Modality
    • Hand-held ENT Surgical Devices
    • Portable ENT Surgical Devices
    • Fixed ENT Surgical Devices

Connect To an Expert:-https://www.factmr.com/connectus/sample?flag=AE&rep_id=2454

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

To Get All-In Insights On the Regional Landscape of The Report Market, Buy Now:-  https://www.factmr.com/checkout/2454

Fixed ENT Surgical Devices to Hold Over 37% Revenue Share in 2019

Based on modality, three types of devices are present – handheld, portable and fixed. Owing to the popularity of fixed devices, Fact.MR estimates that these devices will continue to account for a higher market share. On the other hand, handheld devices are estimated to account for the second largest revenue in the ENT surgical devices market and will register faster expansion in the coming years.

According to the study, North America dominates the ENT surgical devices market and will account for over one forth revenue share in 2019. The market growth in North America is favored by favorable healthcare reimbursement coverage. In addition, presence of industry leaders in the regions contributes to the higher market revenues.

The study finds that Europe follows North America with the second largest revenues. Europe and APEJ collectively held over half the revenues in 2018. While Europe presents an established market, improving healthcare infrastructure and economic standards in APEJ can be attributed to the growth scenario of the ENT surgical devices market in the coming years.

Some important questions that the ENT Surgical Devices Market report tries to answer exhaustively are: 

  • Key strategic moves by various players in the ENT Surgical Devices Market in recent years with respect to product launches, deals and tie-ups, and mergers and acquisitions, and divestment of shares
  • Which strategies will enable top players in the ENT Surgical Devices Market to expand their geographic footprints
  • Which new business models are expected to change the course of growth of key regional markets in near future
  • Which technologies will witness most attractive research investments and what will be the key sources of funding for startups and new entrants
  • Which products segments have in recent years have seen new, lucrative application areas

Need More Information about Report Methodology? Click here:-https://www.factmr.com/connectus/sample?flag=RM&rep_id=2454

The research attempts to answer many queries such as:

  1. What needs are the leading manufacturers trying to meet by the forecast period 2025?
  2. What challenges will vendors running the ENT Surgical Devices market go through?
  3. What aspects do the consumers look up while buying ENT Surgical Devices?
  4. How will the competitive framework look like between the foreseeable period 2018 to 2025?
  5. At present, who is buying your product or service globally?
  6. Who are your primary contenders?
  7. What will be the cost of the products and facilities across various regions?
  8. What are the trends affecting the performance of the ENT Surgical Devices market?

Read More Trending Reports of Fact.MR: –http://www.globenewswire.com/en/news-release/2018/04/30/1489775/0/en/6-Key-Takeaways-from-Fact-MR-s-Report-on-Drip-Coffee-Machine-Market-for-Forecast-Period-2017-2026.html

Benefits of Fact.MR Study

Fact.MR has gradually established itself as one of the leading market research companies across the globe. Our unique, methodical, and up-to-date approach towards creating high-quality market reports ensures the reports include relevant market insights. Further, our team of analysts leaves no stone unturned while curating market reports in accord with the requirement of our clients.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape

Minimally Invasive Surgery Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Sterile Vials Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

Radiation Proctitis Treatment Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Lung Cancer Diagnostics CA Test Is Expected to Reach US$ 889.3 Mn by the End of 2022

Impact of Covid-19 on Healthcare Industry

With the pandemic plaguing maximum countries across the globe, healthcare industry is witnessing its fair share of ‘ups and downs’. The COVID-19 has placed an enormous strain on the healthcare sector’s workforce, facilities and infrastructure. Despite the endless pressure, healthcare sector is growing at a moderate pace due to the improvement in infrastructure and advancement in technology, healthcare sector is delivering a healthy performance.

According to a recent report by Fact.MR, the global demand for lung cancer diagnostics is anticipated to register 7.3% CAGR throughout the forecast period 2017 to 2022.

Growth of the global lung cancer diagnostics market is mainly attributed to surging developments in the lung cancer-specific biomarkers. Diagnostic tools, such as these, will facilitate personalized treatment approach for lung malignancies.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=49

Numerous biomarkers are in the research pipeline. Epigenomics AG has launched a new test which is based on blood by utilizing DNA methylation biomarkers, and their developments are in process. Initial results of these tests have guaranteed early diagnosis of lung cancer. These incidences are most likely to increase demand for diagnosis of lung cancer across the globe.

10 Key Takeaways from Fact.MR’s Report on the Global Lung Cancer Diagnostics Market

  1. North America is expected to remain dominant in the global lung cancer diagnostics market, with revenues expected to surpass US$ 1,000 Mn by 2022-end.
  2. Europe will continue to be the second most lucrative region for growth of the market, expanding at a high single-digit CAGR through 2022.
  3. CA tests will remain the largest adopted tests for diagnosis of lung cancer. Revenue from CA tests is expected to reach US$ 889.3 Mn by the end of 2022.
  4. Angiogenesis inhibitor tests will exhibit the fastest expansion in the global market for lung cancer diagnostics, followed by HER 2 tests. However, revenue from ALK tests to diagnose lung cancer is estimated to be low in the market throughout the forecast period.
  5. Hospital-associated labs are expected to remain the most lucrative among end-users in the global lung cancer diagnostics market.
  6. Cancer research institutes are expected to register the fastest growth in the global market for lung cancer diagnostics.
  7. Independent diagnostic laboratories are expected to be the second largest end-users of lung cancer diagnostics throughout the forecast period.
  8. Based on indication, even though non-small cell lung cancer will remain sought-after, small cell-lung cancer will exhibit the fastest growth through 2022. Non-small cell lung cancer will continue to account for the largest revenues during the forecast period.
  9. Revenue from small cell lung cancer will continue to be low in the global lung cancer diagnostics market.

Fact.MR’s report profiles key market players, which include

Illumina, Inc.
Abbott Laboratories
Thermo Fischer Scientific Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
NeoGenomics Laboratories, Inc.
NanoString Technologies, Inc.
Myriad Genetics, Inc.
Roche Holding AG
Danaher Corporation.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=49

Global Lung Cancer Diagnostics Market: Segmentation

For clearer understanding of the Lung Cancer Diagnostics Market, analysts have segmented the market. The segmentation has been done on the basis of application, technology, and users. Each segment has been further explained with the help of graphs figures. This breakdown of the market gives the readers an objective view of the global Lung Cancer Diagnostics Market, which is essential to make sound investments.

Market Taxonomy

Test Type End User Indication
CA Test Hospital Associated Labs Non Small-cell Lung Cancer
HER2 Tests Independent Diagnostic Laboratories Small-cell Lung Cancer
ALK Tests Cancer Research Institutes
Angiogenesis Inhibitor Others
EGFR Mutation Tests
KRAS Mutation Tests
Others

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Lung Cancer Diagnostics Market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Segmentation:

Test Type

  • CA Test for Lung Cancer Diagnostics
  • HER2 Tests for Lung Cancer Diagnostics
  • ALK Tests for Lung Cancer Diagnostics
  • Angiogenesis Inhibitor for Lung Cancer Diagnostics
  • EGFR Mutation Tests for Lung Cancer Diagnostics
  • KRAS Mutation Tests for Lung Cancer Diagnostics
  • Others

End-User

  • Lung Cancer Diagnostics  for Hospital Associated Labs
  • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
  • Lung Cancer Diagnostics for Cancer Research Institutes
  • Others

Indication

  • Non-Small-cell Lung Cancer Diagnostics
  • Small-cell Lung Cancer Diagnostics

Following Questions Answers Covered in the Report are:

  • How will the global Lung Cancer Diagnostics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Lung Cancer Diagnostics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Lung Cancer Diagnostics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=49

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

 

Get More Insights –http://www.globenewswire.com/en/news-release/2020/03/17/2001947/0/en/Sales-of-Automotive-Wrap-Films-to-Expand-6X-Between-2019-and-2029-MEA-Poised-to-Turn-Highly-Lucrative-Forecasts-a-New-Fact-MR-Report.html

 

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The Lung Cancer Diagnostics Market report answers the following queries:

  1. What is the largest share held by key players in the market?
  2. What strategies have proven most advantageous in the Lung Cancer Diagnostics Market?
  3. Which region promises largest opportunity for new investors during the forecast period 2021 to 2031?
  4. What factors will most likely present challenges to growth during the forecast period?
  5. What will be the value of total revenues, and at what CAGR will the growth compound during the forecast period 2021 to 2031?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Growing Demand from Blood Banks and Transfusion Centers to Boost Sales of Tissue Blood Thawing Systems: Fact.MR

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data.

Sales of blood thawing systems are gaining momentum as the requirement for 2-bag, 4-bags, and dry plasma thawers has been increasing. With rising demand from blood banks, transfusion centers, hospitals, and diagnostic laboratories, blood thawing system manufacturers are expected to come across significant growth scope over the coming years.

A new report by Fact.MR offers an exhaustive overview of global industry trends, demand-supply patterns, and other crucial factors related to blood thawing systems during the forecast period of 2021 to 2031. According to the report, leading players are eyeing the regional markets of North America and Europe, while Asia Pacific will also emerge as another highly lucrative market for blood thawing systems over the coming years.

For detailed insights on enhancing your product footprint, request for a sample here- 

https://www.factmr.com/connectus/sample?flag=S&rep_id=5772

Key Takeaways from Market Study

  • High demand for dry plasma thawers likely to be witnessed
  • Blood plasma and RBCs to emerge as leading segments in terms of sample
  • Growing demand from blood banks and transfusion centers to boost sales of blood thawing systems
  • The United States to hold major share of the North American market for blood thawing systems
  • Germany to remain the hotspot in Europe for blood thawing systems
  • China remains the epicenter of the world’s fastest-growing market for blood thawing systems – Asia Pacific
  • India, Japan, the United Kingdom, France, Italy, and Canada to maintain positive industry outlook throughout the forecast period

Market Segmentation

Fact.MR’s research study assesses the global blood thawing system market in terms of product type, capacity, sample, end user, and region. This report presents extensive market dynamics and trends associated with different segments of the market, and their influence on the growth prospects of the market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=5772

Product Type
  • Dry Plasma Thawers
  • Wet Plasma Thawers
Capacity
  • 2 Bags
  • 4 Bags
  • 8 Bags
  • Others
Sample
  • Blood Plasma
  • RBCs
  • Platelets
  • Whole Blood
  • Others
End User
  • Blood Banks
  • Transfusion Centers
  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical Companies
  • Others
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa (MEA)

Key Questions Answered in Report

For comprehensive insights on this market adoption, ask an analyst here- 

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5772

  • Which are the most lucrative markets for blood thawing systems?
  • Which factors will impact the demand for blood thawing systems?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the global blood thawing system market?
  • What are the winning strategies of stakeholders in the blood thawing system landscape?

blood thawing system market

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the market during the forecast period.

Country-specific valuation on demand for blood thawing systems has been offered for each regional market, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

For in-depth competitive analysis, buy now- https://www.factmr.com/checkout/5772

Key Competitve Players

  • Fremon Scientific Inc.
  • Helmer Scientific Inc.
  • Barkey GmbH & Co. KG
  • Boekel Scientific
  • KW Scientific Apparatus Srl
  • Cardinal Health
  • Cytiva
  • Sarstedt AG & Co. KG
  • Thermo Fisher Scientific, Inc.
  • Sartorius AG

For More Insights: 

https://www.biospace.com/article/andersen-tawil-syndrome-market-gains-ground-with-government-incentives-towards-rare-disease-treatments-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Topical Ocular Drug Delivery Technology Market Business Opportunities, Survey, Growth Analysis And Industry Outlook

It is anticipated that glaucoma cases will surpass 100 million by 2040, while macular degeneration shall reach nearly 200 million by 2020-end. These increasing cases are poised to heighten prospects for ocular drug delivery market in the forecast period (2020-2025).

Immense research and development is occurring in the ocular drug delivery market. Shortages in bioavailability of such drugs is a key growth driver. Studies have shown that micellar formulations and derivative active pharmaceutical ingredients have immense scope for development. Based on these trends, the global ocular drug delivery technology market is poised to register positive growth. The market is anticipated to expand 1.4x by 2025-end.

To remain ‘ahead’ of your competitors, request a sample

https://www.factmr.com/connectus/sample?flag=S&rep_id=4802

A detailed assessment of the global ocular drug delivery technology market’s value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global ocular drug delivery technology market along with their product portfolio enhances the reliability of this comprehensive research study.

“The global ocular drug delivery technology market is set to burgeon positively. Exhaustive research in development of new drug formulations by leading manufacturers is anticipated to drive the growth forward,” infers a Fact.MR analyst.

Key Takeaways of Global Ocular Drug Delivery Technology Market Study:

  • By technology, topical drug delivery is set to dominate the market, capturing nearly half of the market share. Affordability and introduction of emulsion and suspension forms are attributed as key growth drivers. The topical drugs segment is close behind, expanding 1.4x. Long-term effectiveness and precise drug delivery are important growth drivers.
  • By formulation type, solutions are anticipated to capture the majority share, accounting for more than three-fifths of the global ocular drug delivery technology market. High production volume, high-patient compliance and cost effectiveness are important growth levers.
  • By disease type, macular degeneration is set to dominate the global ocular drug delivery technology market. This is followed by diabetic retinopathy. Each segment is poised to account for more than one-fifth of the market share. Rising prevalence of the diseases is the main driver behind the growth of these segments.
  • By end-user, hospitals are poised to account for a major chunk of the market. This is attributed to availability of trained and qualified personnel and well-equipped healthcare facilities. Moreover, technology integration in hospital systems is also set to brighten growth of the segment.
  • By region, North America shall retain market dominance, attributed to presence of key manufacturers and rising visual impairment cases. A market share of more than half is anticipated for the North American Market. Trailing behind is the Asia-Pacific, anticipated to generate substantial growth opportunities. Advancement of research grants, increasing prevalence of cataract and uveitis and presence of key players shall augment growth. The Asia-Pacific region is set to expand a CAGR of 7.0% in the forecast period.

Speak To Research Analyst For Detailed Insights:

https://www.factmr.com/connectus/sample?flag=AE&rep_id=4802

Global Ocular Drug Delivery Technology Market Segmentation

Fact.MR has studied the global ocular drug delivery technology market with detailed segmentation on the basis of technology type, formulation type, disease type, end-user and region.

Technology Type

Formulation Type

Disease Type

End-user

Region
Topical Solution Glaucoma Hospitals North America
Ocular Inserts:Non-erodibleErodible Suspension Diabetic Retinopathy Ambulatory Surgical Centers Europe
Iontophoresis Emulsion Dry Eye Syndrome Ophthalmic Clinics Asia Pacific
Intraocular Implants:BiodegradableNon-biodegradable Liposomes & Nanoparticles Macular Degeneration Homecare Settings Latin America
In-Situ Gel & Punctal Plugs Ointment Diabetic Macular Edema Middle East & Africa
Others Cataract
Others

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

For critical insights on this market, request for methodology here 

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4802

ocular drug delivery technology market size and growth forecast

Global Ocular Drug Delivery Technology Market: Analysis on Market Size Evaluation

The global ocular drug delivery technology market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for global ocular drug delivery technology market is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent global ocular drug delivery technology market segments, along with market attractiveness evaluation has been incorporated in the report.

Global Ocular Drug Delivery Technology Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the global ocular drug delivery technology report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic and business environment outlook), which are expected to have a momentous influence on the growth of the global ocular drug delivery technology market during the forecast period.

Country-specific valuation on demand for global ocular drug delivery technology has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

For More Insights: 

https://www.biospace.com/article/porokeratosis-treatment-market-is-surging-on-the-back-rising-focus-on-skincare-fact-mr/

Global Ocular Drug Delivery Technology Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading manufacturers of global ocular drug delivery technology products along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of global ocular drug delivery technology products, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, such as product portfolio, key strategies along with an all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the global ocular drug delivery technology market.

Prominent manufacturers with established market presence in the global ocular drug delivery technology market are

  • Ocular Therapeutix, Inc.
  • Alimera Sciences
  • Allergan plc
  • Valeant Pharmaceuticals International (Bausch Health Company) Inc.
  • Santen Pharmaceutical Co., Ltd.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Proliferative Vitreoretinopathy Market Share, Size & Trend | Industry Analysis Report, Forecast to 2027

With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement for vitreoretinal centers has gained importance worldwide. Prevention of PVR development at early stage RRD for preserving visual function in patients has become a primary agenda among medical researchers and clinicians. A recent Fact.MR analysis envisages the proliferative vitreoretinopathy market to reflect a modest 4.0% CAGR during the forecast period (2018-2027).

For detailed insights on enhancing your product footprint, request a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=795

However, establishment of vitreoretinal centers for the provision of advanced ophthalmological procedures is considered impractical, on account of increasing social security costs – a key challenge faced by nations across the globe. In contrast, remarkable advances have been made in medical equipment, and ultra-wide-field scanning laser ophthalmoscope (Optos) is one such advancement. This equipment facilitates the provision of wide-field, noninvasive, and nonmydriatic images, and is being increasingly employed for diagnosis and follow-up of PVR treatment evaluation.

proliferative vitreoretinopathy market

 

Advantages of deep learning in classifying Optus images in RRD have been observed to be slight, however the method has been deemed clinically imperative to achieve higher accuracy. It has been observed that multiple non-linear processing layers in deep learning approach can be leveraged for effective prevention and treatment of proliferative vitreoretinopathy by further studies.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=795

Proliferative Vitreoretinopathy Market: Hospital Pharmacies Continue to Account for Bulk Market Shares

Hospital pharmacies are leading consumers in the pharmacy industry. Policymakers are becoming more aware about importance of offering effective pharmacy services coupled with safe and rational use of medications. In case of proliferative vitreoretinopathy, hospital pharmacies are considered to be radical asset of the modern pharmacy sector. They are vital part of hospitals and clinics, ensuring safe, effective, and economic use of drugs. According to the study, hospital pharmacies will continue to account for bulk shares of the market in the period of forecast.

For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=795

Injectables will remain preferred over other mode of administrations of proliferative vitreoretinopathy management drugs. Treatment of PVR through intravitreal injectables has been considered beneficial as they delivery drugs directly to retina and vitreous. Simplicity of achieving intravitreal injection by doctors is a key factor driving adoption of this method. Subretinal injection has been gaining ground in the treatment of PVR, as it directly affects the resident cells & tissues in subretinal space. However, requirement for highly proficient and stable operators for subretinal injection continues to prevail as a major concern in the healthcare sector.

Proliferative Vitreoretinopathy Market: North America Remains at the Vanguard

North America will continue to be at the forefront of the proliferative vitreoretinopathy market, with approximately two-fifth market revenue share estimated for the region by 2027-end. Favorable government policies and reimbursements provided by the government, along with the occupancy of robust healthcare facilities are key growth determinants for growth of the proliferative vitreoretinopathy market in North America. Additionally, strong penetration of PVR management drugs such as “lornoxicam” has further supported demand for treatment of PVR in the region.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/04/04/1797163/0/en/Operating-Room-Equipment-Demand-Upheld-by-Increasing-Investments-to-Upgrade-Surgical-Rooms-in-Hospitals.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Automated Breast Ultrasound System Is Set to Record a Value CAGR of 9.3% over the Period of Forecast 2027

The global sales of automated breast ultrasound system will exhibit a volume CAGR of 11.1% during the forecast period (2018-2027), according to a new analytical research study of Fact.MR. The report estimates the global revenue share of the automated breast ultrasound system is set to reach nearly US$ 345 Mn in revenues by 2027-end.

ABUS gaining Competitive Edge over HHUS

Breast cancer has prevailed as most commonly diagnosed cancer type, and has become the second leading cause of mortality among women, according to statistics unveiled by National Breast Cancer Foundation. With growing awareness about breast cancer, number of screening procedures has proliferated, thereby propelling demand for advanced diagnostic and follow-up care technologies such as automated breast ultrasound systems in diagnostic centers and hospitals.

To remain ‘ahead’ of your competitors, request a sample 
https://www.factmr.com/connectus/sample?flag=S&rep_id=585

Facilitated screening of denser breast’s tissues, along with the provision of superior image quality, has offered automated breast ultrasound system (ABUS) a competitive edge over the handheld ultrasound system (HHUS).

As automated breast ultrasound system are approved by the FDA for screening in coordination with mammography, in case of women with denser breast tissues, radiologists are increasingly opting for the technology.

On the back of high quality 3D images offered by ABUS, surgeons are employing the system for pre-operative breast evaluation to identify tumor size and location accurately. However, high cost, and lack of skilled radiologists needed for ABUS have made surgeons to opt for HHUS for pre-operative evaluation.

In addition, the Breast Cancer Now Catalyst Programme encouraged and offered tremendous support to research and development in diagnosis and treatment of breast cancer.  Awareness campaigns on breast cancer are further expected to influence demand for automated breast ultrasound system.

Key Takeaways from Fact.MR’s Report on Automated Breast Ultrasound System Market

  • North America will continue to account for bulk share of the global automated breast ultrasound system market. The U.S. is expected to remain the most lucrative country for the market growth in North America, on account of growing breast cancer prevalence and adoption of advanced screening technologies. Presence of leading market participants, favorable government initiatives, and reimbursement scenario are key growth determinants for automated breast ultrasound system market in North America.
  • Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for automated breast ultrasound system through 2027. Revenues from the market in Europe will remain comparatively larger than those from APEJ, and lower than those from North America.
  • On the basis of care type, Hospitals will continue to spearhead the global automated breast ultrasound system market, in terms of revenues. However, revenues from care provided by diagnostic centers will increase at a relatively higher CAGR through 2027.

Speak To Research Analyst For Detailed Insights:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=585

Tested research methodologies employed for developing this report assure that forecasted market size valuations follow a specific growth pattern on the basis of impact of causative factors. This information reveals the dynamics of the global automated breast ultrasound system market across parameter such as

  • Changing regulations on automated breast ultrasound system manufacturing
  • Platforms for cost-effective procurement of raw materials
  • Technological advancements in the working of automated breast ultrasound system
  • Supply chain challenges
  • Impediments for penetrating untapped markets

A cumulative effect of such factors provides the driving force for expansion of the global automated breast ultrasound system market. This study clarifies the impact of growth drivers, sales restraints, market trends and business opportunities with the forecasted findings.

Market Taxonomy

REGION

CARE TYPE
North America Hospitals
Latin America Diagnostic Centers
Europe
Japan
APEJ
MEA

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

For critical insights on this market, request for methodology here 
https://www.factmr.com/connectus/sample?flag=RM&rep_id=585

  • Key market players profiled by Fact.MR’s report

    SonoCine Inc.
  • Koninklijke Philips N.V.
  • Hitachi, Ltd.
  • Siemens AG
  • Delphinus Medical Technologies Inc.
  • GE Healthcare.

Assessing Insights on Expanding Global Footprint

Understanding the lucrativeness of regions is a key challenge for companies in the global automated breast ultrasound system market. Information of country-specific markets and regional undercurrents is being offered to expand the knowledge of automated breast ultrasound system companies. Insights on low-wage countries, regions with favorable industrial regulations and concentered consumer marketplaces can influence the expansion strategies of manufacturers.

The scope of this report is to address major concerns of automated breast ultrasound system manufacturers in terms of product development, sales growth and geographic expansion. Inferences in the report are aimed to help market players take informed steps towards future market direction.

For More Insights: 

https://www.biospace.com/article/ventricular-restoration-systems-market-growth-pursuant-to-successful-feasibility-studies-and-reimbursement-policies/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Disposable Syringes Market: Quantitative Market Analysis, Current And Future Trends

Around 2 million people get infected with diseases such as HIV and hepatitis each year due to reusable syringes. Disposable syringes prevent the plunger being pulled back after an injection so that it cannot be used again. Thus, use of disposable syringes is gaining wide popularity in hospitals in every part of the world. Expected advantages are ensuring sterility and preventing the spread of infections from patient to patient. Parallel to this, there is also the need to improve disposal facilities at hospital. Across regions, demand for plastic-made syringes and cannulas is high, with a market share of close to 95%.

For detailed insights on enhancing your product footprint, request for a sample here-https://www.factmr.com/connectus/sample?flag=S&rep_id=2007

The COVID-19 pandemic has affected the market quiet significantly. The pandemic has surged demand for syringes, which, in turn, has resulted in shortage of syringes. Currently, with the introduction of vaccines for COVID-19, demand for syringes has surged at an unprecedented rate. Many countries are focusing on carrying out vaccination drives, which is leading to the shortage of syringes. For instance, there is growing fear in Japan that millions of doses of the Pfizer vaccine purchased by the government could get wasted due to shortage of special syringes that maximize the number of shots from each vial. Thus, the pandemic is putting great pressure on manufacturers to ramp up the production of syringes.

“The outbreak of COVID-19 and introduction of vaccines into the market are surging demand for syringes and cannulas,”says a Fact.MR analyst.

syringes and cannulas market region

Key Takeaways from Market Study

  • By product, syringes dominate with a market share of more than 90%, and will further observe a rise in market share during the forecast period.
  • Plastics will dominate the market contributing maximum revenue share.
  • Hospitals will account for bulk of the demand through 2030, with more than 35% of market share.
  • North America holds the highest market share due to initiatives taken up through various exchange programs that spread awareness and distribute clean needles and syringes.
  • The market for syringes and cannulas is projected to progress at a healthy CAGR of more than 6% in China and India.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the market are also included in the current study. Depending on potential developments in the syringes and cannulas market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=2007

Key Market Segments

Fact.MR’s study on the syringes and cannulas market offers information divided into four important segments – product, material, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
  • Syringes
    • Reusable Syringes
    • Disposable Syringes
  • Cannulas
    • Neonatal Cannula
    • Straight Cannula
    • Winged Cannula
    • Cannula with Wings and Ports
    • Cannula with Integrated Stop Cocks
    • Nasal Cannula
Material
  • Plastics
  • Metals
  • Elastomers
  • Glass
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cancer Research Centers
  • Nursing Facilities
  • Diagnostic Laboratories
  • Homecare Settings
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)

Get Customization on this Research Report for specific research solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=2007

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for syringe and cannulas?
  • Which factors will induce a change in the demand for syringe and cannulas during the assessment period?
  • How will changing trends impact the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can businesses in the market avail growth the opportunities in developed and emerging sectors?
  • What will be the Impact of the COVID-19 pandemic on the syringes and cannulas market?

Manufacturers Aiming to Strengthen their Position through Acquisitions

Leading manufacturers of medical supplies are focusing on acquisitions and collaborations in order to upsurge their product portfolios and expand their regional presence. This will provide improved patient care while optimizing clinical and economic outcomes.

  • For instance, in January 2019, Cardinal Health announced the acquisition of Mirixa Corporation, a leading organization developing solutions for medication therapy management.
  • In August 2020, B. Braun Medical Inc. and Kerma Medical Product, Inc. announced a collaboration to develop and improve healthcare products and services.

For More Insights https://www.biospace.com/article/absorbable-nonwoven-textiles-demand-driven-by-cross-infection-mitigation-efforts-study/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com